166 related articles for article (PubMed ID: 3048468)
21. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
22. Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging.
Janssen WE; Lee C; Gross S; Gee AP
Exp Hematol; 1989 Mar; 17(3):252-7. PubMed ID: 2917623
[TBL] [Abstract][Full Text] [Related]
23. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.
Uckun FM; Ramakrishnan S; Houston LL
J Immunol; 1985 Mar; 134(3):2010-6. PubMed ID: 3855433
[TBL] [Abstract][Full Text] [Related]
24. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
[TBL] [Abstract][Full Text] [Related]
25. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
Ramakrishnan S; Uckun FM; Houston LL
J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies and magnetic microspheres for the depletion of leukaemic cells from bone marrow harvested for autologous transplantation.
Kemshead JT; Treleaven J; Heath L; Meara AO; Gee A; Ugelstad J
Bone Marrow Transplant; 1987 Aug; 2(2):133-9. PubMed ID: 3332162
[TBL] [Abstract][Full Text] [Related]
27. Malignant leukemic cell separation by iron colloid immunomagnetic adsorption.
Biéva CJ; Vander Brugghen FJ; Stryckmans PA
Exp Hematol; 1989 Sep; 17(8):914-20. PubMed ID: 2670597
[TBL] [Abstract][Full Text] [Related]
28. A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibody.
Rhodes EG; Baker PK; Duguid JK; Davies JM; Cawley JC
Bone Marrow Transplant; 1992 Dec; 10(6):485-9. PubMed ID: 1490198
[TBL] [Abstract][Full Text] [Related]
29. Model experiments for immunomagnetic elimination of leukemic cells from human bone marrow. Presentation of a novel magnetic separation system.
Gruhn B; Häfer R; Müller A; Andrä W; Danan H; Zintl F
Immunobiology; 1991 Nov; 183(5):374-85. PubMed ID: 1786986
[TBL] [Abstract][Full Text] [Related]
30. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
31. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
Montgomery RB; Kurtzberg J; Rhinehardt-Clark A; Haleen A; Ramakrishnan S; Olsen GA; Peters WP; Smith CA; Haynes BF; Houston LL
Bone Marrow Transplant; 1990 Jun; 5(6):395-402. PubMed ID: 2369680
[TBL] [Abstract][Full Text] [Related]
32. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
Uckun FM; Stong RC; Youle RJ; Vallera DA
J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
[TBL] [Abstract][Full Text] [Related]
33. Isolation of hemopoietic precursor cells from human marrow by negative selection using monoclonal antibodies and immunomagnetic beads.
Cottler-Fox M; Bazar LS; Deeg HJ
Prog Clin Biol Res; 1990; 333():277-84. PubMed ID: 2308986
[TBL] [Abstract][Full Text] [Related]
34. Immunomagnetic microsphere mediated purging of cALLa positive leukemic cells from bone marrow for autologous reinfusion.
Janssen WE; Lee C; Johnson KS; Spencer C; Rios AM; Graham-Pole JR; Gross S
Prog Clin Biol Res; 1990; 333():285-92. PubMed ID: 2137931
[TBL] [Abstract][Full Text] [Related]
35. Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow.
Morecki S; Margel S; Slavin S
Cancer Res; 1988 Aug; 48(16):4573-7. PubMed ID: 3396008
[TBL] [Abstract][Full Text] [Related]
36. Removal of neuroblastoma cells from bone marrow by a direct monoclonal antibody rosetting technique.
Berthold F; Schumacher R; Schneider A; Bosslet K; Reiter C
Bone Marrow Transplant; 1989 May; 4(3):273-8. PubMed ID: 2659112
[TBL] [Abstract][Full Text] [Related]
37. Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies.
Vartdal F; Kvalheim G; Lea TE; Bosnes V; Gaudernack G; Ugelstad J; Albrechtsen D
Transplantation; 1987 Mar; 43(3):366-71. PubMed ID: 3103274
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of a modified immunomagnetic procedure for the purging of neuroblastoma cells from bone marrow].
Kremens B; Combaret V; Favrot MC; Laurent JC; Philip T
Monatsschr Kinderheilkd; 1990 Jun; 138(6):331-6. PubMed ID: 2197550
[TBL] [Abstract][Full Text] [Related]
39. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies.
Press OW; Farr AG; Borroz KI; Anderson SK; Martin PJ
Cancer Res; 1989 Sep; 49(17):4906-12. PubMed ID: 2667754
[TBL] [Abstract][Full Text] [Related]
40. Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads.
Vredenburgh JJ; Ball ED
Cancer Res; 1990 Nov; 50(22):7216-20. PubMed ID: 2171759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
